Good evening :)
$
₹
S

SeaStar Medical Holding Corporation

ICUCW

NASDAQ
S

SeaStar Medical Holding Corporation

ICUCW

NASDAQ
$0.017.36% (-0.00)
$
₹
$0.017.36% (-0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Unknown

Sector and industry information not available

Unknown

Recent listing (market-cap unavailable as on date)

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

—
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Peers

Peers

Hmm, looks like data is currently unavailable. Once it's updated, you can view it here

Financials

Financials

Income

Balance Sheet

Cash Flow

0.1
-3.4
0.4
-2.9
0.4
-3.5
0.6
-3.7
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue000.060.060.290.330.180.420.490.61
Net Income-12.69-3.23-4.47-4.41-3.77-2-3.47-2.90-3.52-3.73
Net Profit Margin---6585.29%-6595.52%-1287.37%-592.30%-1897.26%-691.42%-711.31%-606.50%
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. SeaStar Medical Holding Corporation (ICUCW) share price today is $0.01 as of September 5, 2026 at 12:47 AM IST. The stock touched a day high of $0.01 and a day low of $0.01.

  2. SeaStar Medical Holding Corporation stock trades on NASDAQ under the ticker symbol ICUCW.

  3. SeaStar Medical Holding Corporation's market capitalization is N/A as of September 5, 2026 at 12:47 AM IST.

  4. SeaStar Medical Holding Corporation's price-to-earnings (P/E) ratio is N/A as of September 7, 2026.

  5. SeaStar Medical Holding Corporation's price-to-book (P/B) ratio is 0 as of September 7, 2026.

  6. Yes, You can buy SeaStar Medical Holding Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy SeaStar Medical Holding Corporation shares in three steps: 1. Search SeaStar Medical Holding Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since SeaStar Medical Holding Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in SeaStar Medical Holding Corporation (ICUCW) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 662.2516 shares at the current price of $0.01.

Loading...